Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
HIV Infection
Trial Locations (10)

10128

Mount Sinai Medical Center, New York

10467

Children's Hospital at Montefiore Medical Center, The Bronx

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21201

University of Maryland, Baltimore

33101

Children's Diagnostic and Treatment Center, Fort Lauderdale

University of Miami-Jackson Memorial Medical Center, Miami

60612

Cook County Children's Hospital, Chicago

70112

Tulane Medical Center, New Orleans

90027

Children's Hospital of Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00107029 - Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth | Biotech Hunter | Biotech Hunter